Study Scope and Process
One of the primary indicators of patient safety and efficacy in this trial is changes in body temperature over an extended period of time, spanning up to 30 days or more.
This study leveraged the VivaLNK Vitals Data Service using a customized patient app, the continuous temperature monitor, and hosted cloud service to analyze patient temperature while ambulatory and at home.
- Extended continuous monitoring
- Ambulatory impacts to temperature
- Network disruptions in RPM settings
- Axillary temperature